Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
TRIAGE HF™ is designed to integrate the diagnostic data collected by the compatible cardiac implanted device and provide an overall heart failure risk assessment. The risk assessment is based on an analysis of the cardiac device diagnostic data from the previous 30 days to calculate the probability of a heart failure event within the next 30 days.
OptiVol™, Patient Activity, AT/AF Burden, Ventricular Rate during AT/AF, % Ventricular Pacing, Shocks, Treated VT/VF, Night Ventricular Rate, Heart Rate Variability.
TriageHF™-enabled clinics can leverage the technology for all CIED* patients with OptiVol™, with backward compatibility.
HIGH
Hazard Ratio 10x
MEDIUM
Hazard Ratio 2.1x
LOW
Neg Pred Value 99.4%
Prof. Haran Burri (Geneva)
Find additional feature information along with a variety of educational resources and tools.
Visit Medtronic AcademyCompatible with most OptiVol™-enabled devices. Please contact your local Medtronic sales representative for a complete list.
Heart Failure Society of America (HFSA) 22nd Annual Scientific Meeting. “What Do Heart Failure Patients Really Want, and Do Doctors Get it?” - Medscape Medical News - Nov 06, 2018. Available on-line at https://www.medscape.com/viewarticle/904440
Medtronic CareLink™ Heart Failure Risk Status Technical Manual M945636A001 A.
Cowie MR, et al. Eur Heart J. 2013;34:2472-2480.